Platelet-Poor Plasma
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Platelet-Poor Plasma, covering 2015-05-22 to 2019-04-10. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy of Resticutis Compared to Platelet-Poor Plasma for Treating Diabetic Foot Ulcers [Phase 1, Phase 2]